同族・世襲経営の「明暗」(8)私鉄大手最後の同族企業 東武鉄道の「新東京タワー狂い」
スポンサーリンク
概要
論文 | ランダム
- S23-1 Pharmacognetic and biomarkers in oncology(FIP joint conference S23 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
- S23-PL Genomic medicine(FIP joint conference S23 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
- S22-5 Personalised Medicine in 2020(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
- S22-4 Pharmacokinetics and Pharmacogenomics in esophageal cancer chemoradiotherapy(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
- S22-3 Pharmaco-proteomics and metabolomics for personalized medicine(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)